Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.
Michael Smith Laboratories, UBC, Vancouver, British Columbia, Canada.
J Parkinsons Dis. 2021;11(1):153-158. doi: 10.3233/JPD-202237.
The gut microbiome has been increasingly implicated in Parkinson's disease (PD); however, most existing studies employ bacterial-specific sequencing, and have not investigated non-bacterial microbiome constituents. Here, we use fungal-specific internal transcribed spacer (ITS)-2 amplicon sequencing in a cross-sectional PD cohort to investigate associations between the fungal gut microbiome and PD. Fungal load among participants was extremely low, and genera identified were almost exclusively of proposed dietary or environmental origin. We observed significantly lower fungal DNA relative to bacterial DNA among PD patients. No fungi differed in abundance between patients and controls, nor were any associated with motor, cognitive, or gastrointestinal features among patients.
肠道微生物组与帕金森病(PD)的关系日益受到关注;然而,大多数现有研究采用细菌特异性测序方法,并未探究非细菌微生物组成分。在此,我们在 PD 横断面研究中采用真菌特异性内部转录间隔区(ITS)-2 扩增子测序,研究肠道真菌微生物组与 PD 的相关性。研究对象的真菌负荷极低,鉴定出的菌属几乎全部来源于饮食或环境。与健康对照组相比,PD 患者的真菌 DNA 相对细菌 DNA 明显减少。患者和对照组之间的真菌丰度没有差异,也没有任何真菌与患者的运动、认知或胃肠道特征相关。